Evidence mapPaperPMID 41279706Full record

ArticlebioRxiv : the preprint server for biology2025

Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART.

Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert Blair, Ahmad Saied, Sergiy Sukhanov, Jay Kolls, Woong-Ki Kim, Patrice Delafontaine and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yilin ChenTulane National Biomedical Research Center, Covington, LA 70433, USA.
Xiaofeng DingTulane National Biomedical Research Center, Covington, LA 70433, USA.
Sonalika RayLouisiana Biomedical Research Network, Louisiana State University, Baton Rouge, USA.
Siva ThirugnanamTulane National Biomedical Research Center, Covington, LA 70433, USA.
Robert BlairTulane National Biomedical Research Center, Covington, LA 70433, USA.
Ahmad SaiedTulane National Biomedical Research Center, Covington, LA 70433, USA.
Sergiy SukhanovDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jay KollsDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Woong-Ki KimTulane National Biomedical Research Center, Covington, LA 70433, USA.
Patrice DelafontaineDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jay RappaportTulane National Biomedical Research Center, Covington, LA 70433, USA.
Xuebin QinTulane National Biomedical Research Center, Covington, LA 70433, USA.
Namita RoutTulane National Biomedical Research Center, Covington, LA 70433, USA.ORCID 0000-0003-0609-0767

Funding

CTSA UM1 at the University of Alabama at BirminghamUM1TR004771 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2024 to 2025
$19.6M
Tulane National Primate Research CenterP51OD011104 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$9.3M
Insulin-Like Growth Factor-1and AtherosclerosisR01HL070241 · UNIVERSITY OF KANSAS MEDICAL CENTER · 2003 to 2025
$1.8M
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammationR01DK131930 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$721k
Role of Complement Activation in Severe COVID-19R01HL165265 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$674k
Renal Macrophage BiologyR01DK129881 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$460k
NCATS NIH HHS UM1 TR004771NHLBI NIH HHS R01 HL070241NHLBI NIH HHS R01 HL141132NHLBI NIH HHS R01 HL142796NHLBI NIH HHS R01 HL165265NIDDK NIH HHS R01 DK129881NIDDK NIH HHS R01 DK131930NIDDK NIH HHS R56 DK131531NIGMS NIH HHS P20 GM103629NIH HHS P51 OD011104
6 · The paper itself

Abstract

Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) experience persistent inflammation, immune dysfunction, and premature onset of cardiovascular and aging-related comorbidities. To define the underlying mechanisms, we performed longitudinal transcriptomic profiling in peripheral blood mononuclear cells (PBMCs) from a cohort of simian immunodeficiency virus (SIV)-infected rhesus macaques spanning four key stages: pre-infection, acute infection, short-term ART, and long-term ART. Bulk RNA sequencing revealed dynamic immune remodeling across infection and treatment. Acute SIV infection induced robust antiviral and inflammatory programs, with upregulation of interferon-stimulated genes (ISGs), IL-27, JAK/STAT, and NF-κB signaling, coupled with suppression of T- and B-cell activation pathways. Short-term ART effectively reversed these transcriptional perturbations, restoring adaptive immune gene expression and reducing innate antiviral responses to near-baseline levels. In contrast, chronic SIV infection on long-term ART maintained viral suppression but was characterized by reactivation of innate immune pathways, including TLR2/TLR4/MYD88, NF-κB, and inflammasome (NLRP3/or NLRP12, caspase-1) signaling, along with sustained macrophage activation, platelet/coagulation signaling, and senescence-associated secretory phenotype. Protein analyses confirmed persistent CASPASE-1 and NF-κB activation in spleen tissue. Pathologic evaluation of a carotid artery from an SIV-infected, long-term ART-treated macaque revealed macrophage-rich plaques with p21

Indexed as

ARTatherosclerosiscaspase-1IL-27inflammagingmacrophageNFκBRNA-seqSIV

Identifiers

PMID41279706
PMCPMC12637440

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.